Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|269-277

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-07, pp. : 269-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serial Topoisomerase II Expression in Primary Breast Cancer and Response to Neoadjuvant Anthracycline-Based Chemotherapy

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 388-394

Karger

Access to resources Recommend Favorite

Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 30-38

Karger

Access to resources Recommend Favorite

Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea

By  

Oncology, Vol. 91, Iss. 5, 2016-09 ,pp. : 274-282

Karger

Access to resources Recommend Favorite

Are Changes in Circulating Tumor Cell (CTC) Count Associated with the Response to Neoadjuvant Chemotherapy in Local Advanced Breast Cancer? A Meta-Analysis

By  

Oncology Research and Treatment, Vol. 37, Iss. 5, 2014-04 ,pp. : 250-254

Karger

Access to resources Recommend Favorite